Ocorrncia de hemoparasitos e ectoparasitos em veado-catingueiro (Mazama gouazoubira Fischer 1814), veado-campeiro (Ozotocerus bezoarticus Linnaeus 1758) e cervo-do-pantanal (Blastocerus dichotomus Illiger 1815): utilizao de mtodos parasitolgicos e moleculares (Belo Horizonte, Minas Gerais, Brazil: Universidade Federal de Minas Gerais)
This is not a simple case of a business closing its doors
Lifestyle and Self-Care Strategies Lifestyle habits cannot replace treatment, but they make recovery stronger and more sustainable
Fernandez-Barrena: Nothing to Disclose, Laura Alvarez: Nothing to Disclose, Colm O'Rourke: Nothing to Disclose, Pui-Yuen Lee-Law: Nothing to Disclose, Kyle Davies: Nothing to Disclose, Andreea Gradinaru: Nothing to Disclose, Raul Jimenez-Aguero: Nothing to Disclose, Adelaida La Casta: Nothing to Disclose, Ioana Riao: Nothing to Disclose, Rocio Macias: Nothing to Disclose, Jose J G Marin: Nothing to Disclose, Maria L Martinez-Chantar: Nothing to Disclose, Matias A Avila: Nothing to Disclose, Patricia Aspichueta: Nothing to Disclose, Jesper B Andersen: Nothing to Disclose, Luke Boulter: Nothing to Disclose, Luis Bujanda: Nothing to Disclose, Pedro M Rodrigues: Nothing to Disclose, Maria J Perugorria: Nothing to Disclose, Jesus M Banales: Nothing to Disclose 1936 THE INVOLVEMENT OF MICRORNA-1297 IN LENVATINIB RESISTANCE IN HEPATOCELLULAR CARCINOMA CELLS Takayuki Kogure 1 Mari Satoh 1 Takehito Ito 1 Kennichi Satoh 1 , 1 Tohoku Medical and Pharmaceutical University Background: Lenvatinib for treating hepatocellular carcinoma (HCC) has a superior response rate, although its overall survival is non-inferior to sorafenib, suggesting tumor cells may acquire resistance during therapy
Accessed 2 Mar 2023 Schieffer E, Schieffer B (2022) The rationale for the treatment of long-Covid symptomsa cardiologists view
